IP Library Granted Patent US 11,071,765
Granted Patent B2
US 11,071,765 · App. 16/349,518 · Granted Jul 27, 2021

Herbal compositions comprising extracts of

Inventors: Ganga Raju Gokaraju (Vijaywada, IN); Rama Raju Gokaraju (Vijayawada, IN); Trimurtulu Golakoti (Vijayawada, IN); Kiran Bhupathiraju (Vijayawada, IN); Krishanu Senguptha (Vijayawada, IN); Venkata Kanaka Ranga Raju Gokaraju (Vijayawada, IN); Venkata Krishna Raju Alluri (Vijayawada, IN)
Assignee: LAILA NUTRACEUTICALS
A61K36/68A23L33/105A61K36/80A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,765
App. No.
16/349,518
Granted
Jul 27, 2021
Kind
B2
Abstract

The present invention relates to synergistic compositions comprising extracts or fractions derived from Bacopa monnieri in combination with extracts or fractions derived from Terminalia chebula for improving brain health, memory/mental condition, enhancing brain/mental functions such as cognition, memory, learning, retention, communication and for treating neurodegenerative diseases/disorders such as Alzheimer's disease, Parkinson's disease etc. The invention further relates to method of improving brain health and brain functions selected from cognition, memory, memory retention, information recall, intelligence, motivation, attention, concentration, learning power and communication and to alleviate disease conditions related to cognition and memory deficits in a mammal by supplementing the mammal with an effective dose of the synergistic composition comprising at least one extract or fraction derived from Bacopa monnieri in combination with at least extract or fraction derived from Terminalia chebula.

Claims (56)

1. An herbal composition comprising:

an effective amount of an extract of Bacopa monnieri ; and

an effective amount of an extract of Terminalia chebula fruit;

wherein the herbal composition is effective for at least one of:

enhancing memory;

enhancing cognition; and

treating a cognition or memory deficit; and

wherein the extract of Bacopa monnieri and the extract of Terminalia chebula fruit are present in a ratio ranging from 1:3 to 3:1.

2. The herbal composition as claimed in claim 1 , further comprising at least one component selected from the group consisting of:

a pharmaceutically or nutraceutically or dietically acceptable excipient, carrier, or diluent;

a biological agent;

an antioxidant,

an anti-inflammatory agent, an immune modulator; and

a nootropic agent.

3. The herbal composition as claimed in claim 2 , wherein the pharmaceutically or nutraceutically or dietically acceptable excipient, carrier, or diluent is selected from the group consisting of glucose, fructose, sucrose, maltose, yellow dextrin, white dextrin, aerosil, microcrystalline cellulose, calcium stearate, magnesium stearate, sorbitol, stevioside, corn syrup, lactose, citric acid, tartaric acid, malic acid, succinic acid, lactic acid, L-ascorbic acid, dl-alpha-tocopherol, glycerin, propylene glycol, glycerin fatty ester, poly glycerin fatty ester, sucrose fatty ester, sorbitan fatty ester, propylene glycol fatty ester, acacia, carrageenan, casein, gelatin, pectin, agar, vitamin B group, nicotinamide, calcium pantothenate, amino acids, proteins, calcium salts, pigments, flavors, preservatives, distilled water, saline, aqueous glucose solution, alcohol, propylene glycol and polyethylene glycol, various animal and vegetable oils, white soft paraffin, paraffin, flavorants, colourants, wax, and a mixture thereof.

4. The herbal composition as claimed in claim 2 , wherein the herbal composition is formulated into a dosage form.

5. The herbal composition as claimed in claim 4 , wherein the dosage form is selected from the group consisting of a dry powder, a liquid, a beverage, a food product, a dietary supplement, a tablet, a capsule, a soft chewable form, and a gummy candy.

6. The herbal composition as claimed in claim 2 , wherein the herbal composition is formulated into a solid food, a semisolid food, a beverage, a drop, a candy, a chewing gum, a gummy candy, yoghurt, ice cream, pudding, soft adzuki bean jelly, a jelly, a cookie, a tea, a soft drink, a juice, milk, coffee, a cereal, or a snack bar.

7. The herbal composition as claimed in claim 2 , wherein the herbal composition is formulated into:

a solid food selected from the group consisting of a chocolate bar and a nutritional bar;

a semisolid food selected from the group consisting of a cream, a jam, a gel; or

a beverage; or

a lactic acid bacteria beverage.

8. An herbal composition comprising:

an effective amount of an extract of Bacopa monnieri ; and

an effective amount of an extract of Terminalia chebula;

wherein the herbal composition is effective for at least one of enhancing memory, enhancing cognition, and treating a cognition or memory deficit;

wherein the extract of Bacopa monnieri and the extract of Terminalia chebula are present in a ratio ranging from 1:3 to 3:1; and

wherein the extract of Bacopa monnieri contains from 20% to 70% total bacosides, based on an analysis by UV spectroscopy.

9. The herbal composition as claimed in claim 1 , wherein the extract of Bacopa monnieri contains from 5% to 25% total bacosides, based on an analysis by HPLC.

10. The herbal composition as claimed in claim 8 , wherein the extract of Terminalia chebula contains from 20% to 80% total polyphenols, based on an analysis by UV spectroscopy.

11. An herbal composition comprising:

an effective amount of an extract of Bacopa monnieri ; and

an effective amount of an extract of Terminalia chebula fruit;

wherein the herbal composition is effective for at least one of enhancing memory, enhancing cognition, and treating a cognition or memory deficit;

wherein the extract of Bacopa monnieri and the extract of Terminalia chebula fruit are present in a ratio ranging from 1:3 to 3:1; and

wherein the extract of Terminalia chebula fruit contains at least one of:

1 to 6% total chebulagic acids;

1-12% total chebulinic acid;

1 to 10% ellagic acid; and

1 to 10% gallic acid,

based on an analysis by HPLC.

12. The herbal composition as claimed in claim 1 , wherein the extract of Bacopa monnieri is obtained from at least one plant part selected from the group consisting of a fruit, aerial parts or leaves, a whole plant, and a mixture thereof.

13. The herbal composition as claimed in claim 1 , wherein the extracts of Bacopa monnieri and Terminalia chebula fruit are prepared using a solvent selected from the group consisting of a C1-C5 alcohol; a ketone; a chlorinated solvent; water; C1-C7 hydrocarbons; esters; and mixtures thereof.

14. The herbal composition as claimed in claim 1 , wherein the extracts of Bacopa monnieri and Terminalia chebula fruit are prepared using a solvent selected from the group consisting of ethanol, methanol, n-propanol, isopropyl alcohol, acetone, methyl isobutyl ketone, methylene dichloride, chloroform, water, hexane, ethyl acetate, and mixtures thereof.

15. An herbal composition comprising:

from 25% to 75% by weight of an extract of Bacopa monnieri , wherein the extract of Bacopa monnieri contains from 20% to 70% total bacosides, based on an analysis by UV spectroscopy; and

from 25% to 75% by weight of an extract of Terminalia chebula , wherein the extract of Terminalia chebula contains from 20% to 80% total polyphenols, based on an analysis by UV spectroscopy,

based on the combined weight of the Bacopa monnieri and Terminalia chebula extracts;

wherein the extract of Bacopa monnieri and the extract of Terminalia chebula are the only herbal ingredients in the herbal composition.

16. The herbal composition as claimed in claim 15 , further comprising at least one component selected from the group consisting of:

a pharmaceutically or nutraceutically or dietically acceptable excipient, carrier, or diluent;

a biological agent;

an antioxidant,

an anti-inflammatory agent, an immune modulator; and

a nootropic agent.

Assignments (2)
CHANGE OF NAME Recorded Aug 18, 2025
From: LAILA NUTRACEUTICALS
To: LAILA NUTRA PRIVATE LIMITED
Reel/Frame 072508/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2019
From: GOKARAJU, GANGA RAJU; GOKARAJU, RAMA RAJU; GOLAKOTI, TRIMURTULU; BHUPATHIRAJU, KIRAN; SENGUPTHA, KRISHANU; GOKARAJU, VENKATA KANAKA RANGA RAJU; ALLURI, VENKATA KRISHNA RAJU
To: LAILA NUTRACEUTICALS
Reel/Frame 050442/0395 →
Priority Claims (1)
IN 201641038595 · Nov 11, 2016 · national
Continuity (1)
Related Publication 20190336555A1 · Nov 7, 2019